PRA Health Sciences

$112.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.36 (+1.22%) As of 9:44 AM EST today

Why Robinhood?

You can buy or sell PRAH and other stocks, options, and ETFs commission-free!

About PRAH

PRA Health Sciences, Inc. engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. It operates through Clinical Research and Data Solutions segment. The Clinical Research segment serves biopharmaceutical clients and offers outsourced clinical research and clinical trial related services. The Data Solutions segment involves in data and analytics; technology solutions and real-world insights; and services primarily to the company's life science clients. The company was founded in 1976 and is headquartered in Raleigh, NC. The listed name for PRAH is PRA Health Sciences, Inc. Common Stock.

CEO

Colin Shannon

Employees

17,500

Headquarters

Raleigh, North Carolina

Founded

1976

Market Cap

7.12B

Price-Earnings Ratio

32.83

Dividend Yield

—

Average Volume

287.95K

High Today

$112.44

Low Today

$110.51

Open Price

$112.44

Volume

3.87K

52 Week High

$118.44

52 Week Low

$58.67

Collections

Analyst Ratings

33%

of 15 ratings

Buy

33%

Hold

53%

Sell

13%

PRAH Earnings

$0.00

$0.51

$1.03

$1.54

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 18, After Hours